Vitamin D3 500 IU per gummy
Several important safety considerations from UK SmPCs include: Pancreatitis risk : Seek immediate medical attention for severe, persistent abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Diabetic retinopathy complications : Particularly with semaglutide in those with pre-existing retinopathy Dehydration and acute kidney injury : Possible with severe gastrointestinal side effects Hypoglycaemia : Increased risk when used with insulin or sulfonylureas (dose adjustment of these medications may be needed) Pregnancy/breastfeeding : Weight management GLP-1 agonists (Wegovy, Saxenda) are contraindicated in pregnancy and should be avoided during breastfeeding [5] [2] Regarding mental health specifically, regulatory agencies have scrutinised GLP-1 medications for potential psychiatric adverse effects
Drowsiness, sleepiness, or tiredness You need to be careful about driving or heavy equipment operation Coordination problems (clumsiness, stumbling, awkward movement) Nausea and vomiting Unexplained Headaches Vision problems (blurred or double vision, unusual eye movements) Weight gain Dry mouth, constipation, or diarrhea Flu-like symptoms (fever, sore throat, body aches) Difficulty speaking Prescribing Gabapentin for CTS could be considered Medical Malpractice Recommending Gabapentin for CTS borders on medical malpractice
In type 1 diabetes mouse models, these effects appeared to be dose-dependent
